The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Regulatory News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.00
Bid: 30.00
Ask: 30.60
Change: 0.65 (2.19%)
Spread: 0.60 (2.00%)
Open: 30.70
High: 30.70
Low: 30.00
Prev. Close: 29.65
EKF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

25 Apr 2023 16:10

RNS Number : 4268X
EKF Diagnostics Holdings PLC
25 April 2023
 

EKF Diagnostics Holdings plc

("EKF" or the "Company")

 

Total Voting Rights

 

EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostics business, refers to its announcement dated 23 March 2023 regarding the disposal of Advanced Diagnostic Laboratory LLC ("ADL Health") (the "Disposal").

 

Part of the consideration for ADL Health comprised the return of 1,200,000 ordinary shares of 1p each in the capital of the Company ("Ordinary Shares") which had originally been issued as part of the payment made to the vendors of ADL Health when it was acquired by EKF in 2021. The Company now confirms that these 1,200,000 Ordinary Shares have now been received by EKF and are being held in treasury.

 

As a result, the Company's total issued share capital now consists of 454,930,564 Ordinary Shares with one voting right per share. The Company holds 1,200,000 Ordinary Shares in treasury. The total number of voting rights in the Company is therefore 453,730,564.

 

The above figure of 453,730,564 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

EKF Diagnostics Holdings plc

www.ekfdiagnostics.com

Julian Baines, Executive Chair / Marc Davies, CFO

 Tel: +44 (0)29 2071 0570

Singer Capital Markets (Nominated Adviser & Broker)

Tel: +44 (0)20 7496 3000

Aubrey Powell / George Tzimas / Oliver Platts

Walbrook PR Limited

Tel: +44 (0)20 7933 8780 or ekf@walbrookpr.com

Paul McManus / Lianne Applegarth

Mob: +44 (0)7980 541 893 / +44 (0)7584 391 303

 

About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)

 

EKF is an AIM-listed global diagnostics business focussed on:

 

· Point-of-Care analysers in the key areas of Hematology and Diabetes, as well as Central Laboratory products including clinical chemistry reagents, analysers and centrifuges

 

· Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic food and industrial applications, as well as other higher value Contract Manufacturing services

 

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREASLSAEDDEFA
Date   Source Headline
12th Sep 20167:00 amRNSHalf-year Report
16th Aug 20167:00 amRNSNotice of Results
21st Jul 20168:51 amRNSDirector/PDMR Shareholding
18th Jul 20165:12 pmRNSHolding(s) in Company
18th Jul 20164:06 pmRNSDirector/PDMR Shareholding
15th Jul 20161:44 pmRNSHolding(s) in Company
12th Jul 20161:20 pmRNSHolding(s) in Company
12th Jul 20167:00 amRNSDirector/PDMR Shareholding
11th Jul 20167:00 amRNSDirectorate Change
6th Jul 20167:00 amRNSTrading Update
27th Jun 20164:00 pmRNSDirector/PDMR Shareholding
24th Jun 20163:41 pmRNSDirector/PDMR Shareholding
22nd Jun 20163:49 pmRNSDirector/PDMR Shareholding
22nd Jun 20163:09 pmRNSHolding(s) in Company
21st Jun 20161:09 pmRNSDirector/PDMR Shareholding
10th Jun 20164:20 pmRNSDirector Dealing
9th Jun 201612:20 pmRNSHolding(s) in Company
2nd Jun 20163:44 pmRNSResults of Placing
2nd Jun 201611:43 amRNSResult of AGM
2nd Jun 20167:01 amRNSProposed Placing
2nd Jun 20167:00 amRNSAGM Statement
27th May 20163:17 pmRNSHolding(s) in Company
25th May 201612:47 pmRNSHolding(s) in Company
9th May 20167:00 amRNSDirectorate Change
3rd May 20167:00 amRNSPosting of Annual Report & Notice of AGM
26th Apr 20167:00 amRNSLoan redemption update
22nd Apr 20169:22 amRNSNotice of AGM
20th Apr 20164:40 pmRNSSecond Price Monitoring Extn
20th Apr 20164:35 pmRNSPrice Monitoring Extension
20th Apr 201611:54 amRNSDirectorate Change
15th Apr 20163:53 pmRNSNotice of loan redemption
11th Apr 20168:37 amRNSDirectorate Change
8th Apr 20167:00 amRNSDirectorate Change
4th Apr 20167:00 amRNSNotice of Results
22nd Mar 20165:25 pmRNSHolding(s) in Company
21st Mar 20165:52 pmRNSHolding(s) in Company
21st Mar 20165:45 pmRNSHolding(s) in Company
21st Mar 20161:48 pmRNSHolding(s) in Company
17th Mar 20164:40 pmRNSSecond Price Monitoring Extn
17th Mar 20164:35 pmRNSPrice Monitoring Extension
16th Mar 20164:55 pmRNSNotice of Results
3rd Feb 20167:00 amRNSTrading Update
19th Jan 20162:44 pmRNSHolding(s) in Company
18th Jan 20164:35 pmRNSPrice Monitoring Extension
18th Jan 201611:56 amRNSHolding(s) in Company
15th Jan 20163:11 pmRNSHolding(s) in Company
23rd Dec 20157:00 amRNSSale of Selah
22nd Dec 20152:17 pmRNSFundraising
21st Dec 20157:00 amRNSAppointment of a Director
14th Dec 201512:51 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.